References
- Parisini A, Boni S, Vacca EB, Bobbio N, Del Puente F, Feasi M, et al. Impact of the COVID-19 Pandemic on Epidemiology of Antibiotic Resistance in an Intensive Care Unit (ICU): The Experience of a North-West Italian Center. Antibiotics (Basel). 2023;12(8):1278. DOI: 10.3390/antibiotics12081278
- Boccabella L, Palma EG, Abenavoli L, Scarlata GGM, Boni M, Ianiro G, et al. Post-Coronavirus Disease 2019 Pandemic Antimicrobial Resistance. Antibiotics (Basel). 2024;13(3):233. DOI: 10.3390/antibiotics13030233
- Malik SS, Mundra S. Increasing Consumption of Antibiotics during the COVID-19 Pandemic: Implications for Patient Health and Emerging Anti-Microbial Resistance. Antibiotics (Basel). 2022;12(1):45. DOI: 10.3390/antibiotics12010045
- Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268-81. DOI: 10.1111/j.1469-0691.2011.03570.x
- Su C, Zhang Z, Zhao X, Peng H, Hong Y, Huang L, et al. Changes in prevalence of nosocomial infection pre- and post-COVID-19 pandemic from a tertiary Hospital in China. BMC Infect Dis. 2021;21:693. DOI: 10.1186/s12879-021-06396-x
- Huang H, Wu K, Chen H, Wang J, Chen L, Lai Z, Lin S. The impact of the COVID-19 pandemic on nosocomial infections: a retrospective analysis in a tertiary maternal and child healthcare hospital. Front Public Health. 2023; 11:1132323. DOI: 10.3389/fpubh.2023.1132323
- Witt LS, Howard-Anderson JR, Jacob JT, Gottlieb LB. The impact of COVID-19 on multidrug-resistant organisms causing healthcare-associated infections: a narrative review. JAC-Antimicrobial Resistance. 2023; 5(1):dlac130. DOI: 10.1093/jacamr/dlac130
- Lepape A, Machut A, Bretonnière C, Friggeri A, Vacheron CH, Savey A. Effect of SARS-CoV-2 infection and pandemic period on healthcare-associated infections acquired in intensive care units. Clin Microbiol Infect. 2023; 29(4):530-6. DOI: 10.1016/j.cmi.2022.10.023
- Nori P, Cowman K, Chen V, Bartash R, Szymczak W, Madaline T, et al. Bacterial and fungal coinfections in COVID-19 patients hospitalized during the New York city pandemic surge. Infect Control Hosp Epidemiol. 2021; 42:84-8. DOI: 10.1017/ice.2020.368
- Golli AL, Zlatian OM, Cara ML, Olteanu M. Pre- and Post-COVID-19 Antimicrobial Resistance Pattern of Pathogens in an Intensive Care Unit. Pharmaceuticals. 2024 Mar 22;17(4):407. DOI: 10.3390/ph17040407
- Langford BJ, So M, Raybardhan S, Leung V, Westwood D, MacFadden DR, et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect. 2020; 26:1622-9. DOI: 10.1016/j.cmi.2020.07.016
- Vulcanescu DD, Avram CR, Oprison LA, Tanasescu S, Sorescu T, Susan R, et al. Bacterial Infections, Trends, and Resistance Patterns in the Time of the COVID-19 Pandemic in Romania-A Systematic Review. Antibiotics. 2024 Dec 14;13(12):1219. DOI: 10.3390/antibiotics13121219
- Mares C, Petca RC, Petca A, Popescu RI, Jinga V. Does the COVID Pandemic Modify the Antibiotic Resistance of Uropathogens in Female Patients? A New Storm? Antibiotics. 2022;11:376. DOI: 10.3390/antibiotics11030376
- Mares C, Petca RC, Popescu RI, Petca A, Geavlete BF, Jinga V. Uropathogens’ Antibiotic Resistance Evolution in a FemalePopulation: A Sequential Multi-Year Comparative Analysis. Antibiotics. 2023;12:948. DOI: 10.3390/antibiotics12060948